1. Hasenfuß G (für die Konsensuskommission Klug entscheiden der DGIM): Klug entscheiden: ... in der Notaufnahme. Dtsch Arztebl 2018; 115 (15): A-704/B-606/C-608.

2. Ad-hoc-Kommission „Gemeinsam Klug entscheiden“ der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (Hrsg.): Manual Entwicklung von Empfehlungen im Rahmen der Initiative Gemeinsam Klug entscheiden (GKE). Version 1.0 vom 15.09.2015 (Konsultationsfassung). www.awmf.org medizin-versorgung/gemeinsam-klug-ent scheiden.html (last accessed on 8 April 2019).

3. Hasenfuß G, Fölsch UR: Klug-entscheidenInitiative: Geschichte, Methodik, ethische Aspekte und internationale Ausbreitung. Z Evid Fortbild Qual Gesundhwes 2017; 129: 1–2.

4. Arora S, Cheng D, Wyler B, Menchine M: Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med 2012; 30: 481–4.

5. Barski L, Nevzorov R, Rabaev E, et al.: Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J 2012; 14: 299–303.

6. Olmos P, Donoso A, Arab JP, et al.: Treatment of diabetic ketoacidosis using 2009 American Diabetes Association guidelines. Rev Med Chil 2014; 142: 1267–74.

7. Mårtensson J, Bailey M, Venkatesh B, et al.: Intensity of early correction of hyperglycaemia and outcome of critically ill patients with diabetic ketoacidosis. Crit Care Resusc 2017; 19: 266–73.

8. Haas NL, Gianchandani RY, Gunnerson KJ, et al.: The Two-Bag Method for Treatment of Diabetic Ketoacidosis in Adults Emerg Med 2018; 54: 593–9.

9. Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G: Data were collected in a standardized form covering clinical and biochemical outcomes, risk and discharge National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med 2016; 33: 252–60.

10. Auburtin M, Wolff M, Charpentier J, et al.: Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006; 34: 2758–65.

11. Proulx N, Fréchette D, Toye B, Chan J, Kravcik S: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005; 98 (4): 291–8.

12. Brouwer MC, McIntyre P, Prasad K, van de Beek D: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2013; 6: CD004405.

13. van de Beek D, Cabellos C, Dzupova O, et al.: ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 2016; 22 (3): S37–62.

14. Pfister HW, et al.: Deutsche Gesellschaft für Neurologie (Hrsg.): S2k-Leitlinie: Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter 2015. www.awmf.org/uploads/tx_szleitlini en/030–089l_S2k_Ambulant_erworbene _Meningoenzephalitis_2016-08-verlaengert_01.pdf) (last accessed on 8 April 2019).

15. Kuderer NM, et al.: Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006; 106 (10): 2258–66.

16. Heinz WJ, et al.: Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2017; 96 (11): 1775–92.

17. Ferrer R, et al.: Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42 (8): 1749–55.

18. Perron T, Emara M, Ahmed S: Time to antibiotics and outcomes in cancer patients with febrile neutropenia. BMC Health Serv Res 2014; 14: 162.

19. Klastersky J, Paesmans M, Rubenstein EB, et al.: The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18 (16): 3038–51.

20. Soar J, Nolan JP, Böttiger BW, et al.: European Resuscitation Council Guidelines for Resuscitation 2015 Section 3. Adult advanced life support. Resuscitaton 2015; 95: 100–47.

21. Michels G, Zinke H, Möckel M, et al.: Empfehlungen zur Ultraschallausbildung in der internistischen Intensiv- und Notfallmedizin: Positionspapier der DGIIN, DEGUM und DGK. Med Klin-Intensivmed 2017; 112 (4): 314–9.

22. Truhlář A, Deakin CD, Soar J, et al.: European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances. Resuscitaton 2015; (95): 148–201.

23. Perera P, Mailhot T, Riley D, Mandavia D: The RUSH exam: Rapid Ultrasound in SHock in the evaluation of the critically lll. Emerg Med Clin North Am 2010; 28 (1): 29–56.

24. Breitkreutz R, Walcher F, Seeger FH: Focused echocardiographic evaluation in resuscitation management: concept of an advanced life support-conformed algorithm. Crit Care Med 2007; 35: S150–61.

25. Via G, Hussain A, Wells M, et al.: International Evidence-Based Recommendations for Focused Cardiac Ultrasound. J Am Soc Echocardiogr 2014; 27 (7): 683.e1–33.

26. Levitov A, Frankel HL, Blaivas M, et al.: Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill PatientsPart II: Cardiac Ultrasonography. Crit Care Med 2016; 44 (6): 1206–27.

27. Tsou P-Y, Kurbedin J, Chen Y-S, et al.: Accuracy of point-of-care focused echocardiography in predicting outcome of resuscitation in cardiac arrest patients: A systematic review and meta-analysis. Resuscitation 2017; 114: 92–9.

28. Nidegger D, Ragot S, Berthelémy P, et al.: Cirrhosis and bleeding: the need for early management. J Hepatol 2003; 39: 509–14

29. Denzer U, Beilenhoff U, Eickhoff A, et al.: S2k-Leitlinie: Qualitätsanforderungen in der gastrointestinalen Endoskopie, AWMF Register Nr. 021–022. Z Gastroenterol 2015; 53: 1496–530.

30. Tripathi D, Stanley AJ, Hayes PC, et al.: U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015; 64: 1680–704.

31. D’Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332–4.

32. Wells M, Chande N, Adams P, et al.: Metaanalysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 2012; 35: 1267–78.

33. Bañares R, Albillos A, Rincón D, et al.: Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35: 609–15.

34. Villanueva C, Ortiz J, Sabat M, et al.: Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 1999; 30: 384–9.

35. Sung JJ, Chung SC, Yung MY, et al.: Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346: 1666–9.

36. Besson I, Ingrand P, Person B, et al.: Sclerotherapy with or without octreotide for acuMEDIZINREPORT A 7 Deutsches Ärzteblatt | Jg. 116 | Heft 18 | 3. Mai 2019 te variceal bleeding. N Engl J Med 1995; 333: 555–60

37. de Franchis R, Baveno VIF: Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743–52.

38. Augustin S, Gonzáles A, Genescà A: Acute esophageal variceal bleeding: current strategies and new perspectives. World J Gastroenterol 2010; 27: 261–74.

39. Seo YS, Park SY, Kim MY, et al.: Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology 2014; 60: 954–63.

40. Wells PS, Anderson DR, Rodger M, et al.: Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349 (13): 1227–35.

41. AWMF, Deutsche Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin: S2-Leitlinie: Diagnostik und Therapie der Venenthrombose und der Lungenembolie. AWMF Leitlininien-Register Nr. 065/002. www.awmf.org/uploads/tx_szleitlini en/065-002l_S2k_VTE_2016-01.pdf (last accessed on 8 April 2019).

42. Brignole M, Moya A, de Lange FJ, et al: ESC Scientific Document Group: 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018; 39 (21): 1883–948.

43. Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M, OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators: Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J 2003; 24: 811–9.

44. Del Rosso A, Ungar A, Maggi R, et al.: Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart 2008; 94: 1620–6.

45. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M: Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 2006; 27: 344–50.

46. Kapoor WN, Peterson J, Wieand HS, Karpf M: Diagnostic and prognostic implications of recurrences in patients with syncope. Am J Med 1987; 83: 700–8.

47. Costantino G, Sun BC, Barbic F, et al.: Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency department. Eur Heart J 2016; 37: 1493–8.

48. Huff JS, Decker WW, Quinn JV, et al.: American College of Emergency Physicians: Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Ann Emerg Med 2007; 49: 431–44.

49. Ibanez B, James S, Agewall S, et al.: 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018; 39: 119–77.

50. Terkelsen CJ, Sorensen JT, Maeng M, et al.: System delay and mortality among patients with stemi treated with primary percutaneous coronary intervention. JAMA 2010; 304: 763–71.

51. Nallamothu BK, Normand SL, Wang Y, et al.: Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: A retrospective study. Lancet 2015; 385: 1114–22.

52. Fordyce CB, Al-Khalidi HR, Jollis JG, et al.: Association of rapid care process implementation on reperfusion times across multiple st-segment-elevation myocardial infarction networks. Circ Cardiovasc Interv 2017; 10 (1). pii: e004061.

53. Bagai A, Jollis JG, Dauerman HL, et al.: Emergency department bypass for st-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: A report from the American Heart Association mission: Lifeline program. Circulation 2013; 128: 352–9.

54. Squire BT, Tamayo-Sarver JH, Rashi P, Koenig W, Niemann JT: Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and falsepositive activation. Prehosp Emerg Care 2014; 18: 1–8.

55. Williams B, Mancia G, Spiering W, et al.: 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39 (33): 3021–104.

56. Leung AA, Nerenberg K, Daskalopoulou SS, et al.: Hypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol 2016; 32: 569–88.

57. Kintscher U, Mahfoud F: Therapy of hypertension – 2015. Dtsch Med Wochenschr 2015; 140: 835–42.

58. Veltkamp R, Deutsche Gesellschaft für Neurologie: Akuttherapie des ischämischen Schlaganfalls 2012. www.dgn.org images/red_leitlinien/LL_2012/pdf/ ll_22_2012_akuttherapie_des_ischmischen_schlaganfalls_update.pdf (last accessed on 8 April 2019).

59. Hasbun R, Abrahams J, Jekel J, et al.: Computed tomography of the head before lumbar puncture in adults with suspected meningitis. NEJM 2001; 345: 1727–33.

60. Salazar L, Hasbun R: Cranial imaging before lumbar puncture in adults with community-acquired meningitis: clinical utility and adherence to the Infectious Diseases Society of America Guidelines. CID 2017; 64: 1657–62.

61. Costerus JM, Brouwer MC, Bijlsma MW, et al.: Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study. Clin Microbiol Inf 2016; 22: 928–33.

62. Ehrenstein BP, Salzberger B, Glück T: Neue Entwicklungen in Diagnostik und Therapie der akuten bakteriellen Meningitis. Med Klin 2005; 100: 325–33.

63. Degraeve A, Clemente M, Huttner B, et al.: Management of suspected meningitis in the emergency department. Rev Med Suisse 2016; 12: 1310–5.

64. Glimaker M, Sjölin J, Akesson S, et al.: Lumbar puncture performed promptly or after neuroimaging in acute bacterial meningitis in adults: a prospective national cohort study evaluating different giudelines. CID 2018; 66: 321–8.

65. Glimaker M, Johansson B, Grindborg Ö, et al.: Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. CID 2015; 60: 1162–9.

66. Tunkel AR, Hartman BJ, Kaplan SL, et al.: Practice guideline for the management of bacterial meningitis. CID 2004; 39: 1267–84.

67. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ: Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32: 101–14.

68. Lo E, Nicolle L, Classen D, et al.: Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29: S41–5.

69. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA: Healthcare Infection Control Practices Advisory Committee: Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010; 31: 319–26.

70. Hooton TM, Bradley SF, Cardenas DD, et al.: Infectious Diseases Society of America: Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625–63.

71. Munasinghe RL, Yazdani H, Siddique M, Hafeez W: Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect Control Hosp Epidemiol 2001; 22: 647–9.

72. Hazelett SE, Tsai M, Gareri M, Allen K: The association between indwelling urinary catheter use in the elderly and urinary tract infection in acute care. BMC Geriatr 2006; 6: 15.

73. Gardam MA, Amihod B, Orenstein P, Consolacion N, Miller MA: Overutilization of indwelling urinary catheters and the development of nosocomial urinary tract infections. Clin Perform Qual Health Care 1998; 6: 99–102.

74. Gokula RR, Hickner JA, Smith MA: Inappropriate use of urinary catheters in elderly patients at a midwestern community teaching hospital. Am J Infect Control 2004; 32: 196–9.

75. Scott RA, Oman KS, Makic MB, et al.: Reducing indwelling urinary catheter use in the emergency department. A successful quality-improvement initiative. J Emerg Nurs 2014; 40: 237–44.

76. Stub D, Smith K, Bernard S, et al.: Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation 2015; 131: 2143–50.

77. Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T: Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev 2016; 12: Cd007160.

78. Moradkhan R, Sinoway LI: Revisiting the role of oxygen therapy in cardiac patients. J Am Coll Cardiol 2010; 56: 1013–6.

79. Zweier JL, Talukder MA: The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181–90.

80. McNulty PH, King N, Scott S, et al.: Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. Am J Physiol Heart Circ Physiol 2005; 288: H1057–62.

81. Hofmann R, James SK, Jernberg T, et al.: Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017; 377: 1240–9.